Menu Content/Inhalt
Search  
Clinical
  • A stringent scientific and regulatory input from Investigational New Drug (IND) to New Drug Application (NDA)

  • We select an ‘entry’ indication to validate a mechanism of action before working on broader indications

  • We conduct clinical trials in the United States, Europe, Eastern Europe, Republic of South Africa and developing countries

  • We coordinate international product pharmacovigilance


Our people have broad clinical and medical expertise that encompasses the whole spectrum of drug discovery and development including proof of principle studies, Phase l and Phase ll studies, Phase lll pivotal trials, compassionate drug use and Phase lV programmes.

We have conducted over 70 clinical trials in 20 countries worldwide in therapeutic areas such as oncology, cardiovascular, endocrinology, immunology, neurology and infectious diseases.